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Background
To examine the prevalence and causal factors of vitamin
D deficiency among HIV-1 infected patients and spe-
cially to assess whether antiretroviral drugs interfere
with vitamin D metabolism.
Methods
We performed a cross-sectional study of a hospital
cohort (n=147) of HIV-1 infected outpatients followed-
up by the same physician. Data were collected between
January 2008 and January 2010. We draw samples for
the measurement of 25(OH)D3, PTHi, serum calcium,
serum phosphate, alkaline phosphatase, CD4+ cell count
and viral load. Data on age, sex, VIH infection risk
group, weight, height, skin color, time since HIV diag-
nosis, duration and stage of the infection (according to
CDC 1983 staging system), as well as duration of typo
of antiretroviral therapy (ART). A nutrition specialist of
the same hospital performed a survey of sunlight exposi-
tion and daily vitamin D intake. We performed bi- and
multivariant analysis to identify risk factor related to
vitamin D deficiency (25(OH)D1<20 µg/L).
Results
Median age was 45 years; 67.3% were males and 89.1%
Caucasians. CD4+ count was < 200 cells/µL in 15.6 %,
and 76.2% had a viral load below 30 copies/ml. Median
serum 25(OH)D level was 21.1 µg/L (IQR 12,8-28,3)
and 47.6% had 25(OH)D < 20 µg/L. Multivariate analysis
of predisposing factor to vitamin D deficiency showed
decreasing risk in summer(OR 0.131, 95% CI 0.05-0.336,
p=0.0001) and fall (OR 0.021, 95% CI 0.005-0.089,
p=0.0001) and increased risk in heterosexual (OR 2.77,
95% CI 1.06-7.21, p=0.036) and with the tenofovir use
(OR 2.71, 95% CI 1.14-6.44, p=0.024). In univariate ana-
lysis, current nevirapine use was protective against
development of vitamin D deficiency (OR 0.42, 95% CI
0.15-0.95, p=0.039). Black race was not a risk factor, but
it was underrepresented in our sample.
Conclusions
Despite the low latitude of Spain, moderate vitamin D
deficiency in HIV infected patients is more prevalent in
our cohort than in the cohorts of Switzerland, Nether-
lands and Boston. It was related to the season, hetero-
sexual risk group and tenofovir use. Nevirapine use was
associated with less risk in univariate analysis.
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